Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia
about
Pathogenesis of human immunodeficiency virus infectionCytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1Nef proteins from diverse groups of primate lentiviruses downmodulate CXCR4 to inhibit migration to the chemokine stromal derived factor 1.Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication.Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients.New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA loadDevelopment of real-time PCR array for simultaneous detection of eight human blood-borne viral pathogens.Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitorsInducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein.Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infectionsInduction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral TherapyIn vitro selection and characterization of human immunodeficiency virus type 2 with decreased susceptibility to lopinavirDendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection.Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra.Antigenic conservation and immunogenicity of the HIV coreceptor binding siteRev-dependent indicator T cell lineGenetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biologyCross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytesCytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4.Nucleoside and nucleotide analogs select in culture for different patterns of drug resistance in human immunodeficiency virus types 1 and 2.Multiplex detection of four pathogenic retroviruses using molecular beacons.In vitro and in vivo activities of AIC292, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivoA broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4.Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity.Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype.Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2Role of CD4 endocytosis in human immunodeficiency virus infection.Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoproteinThe CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion.Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4.Proviral progeny of heterodimeric virions reveal a high crossover rate for human immunodeficiency virus type 2Lv2, a novel postentry restriction, is mediated by both capsid and envelope.Potent suppression of HIV-1 cell attachment by Kudzu root extract
P2860
Q24634681-8F857CC2-0D94-4918-A296-B8E0BF5B45DBQ33811663-276B7375-607D-4228-9BF2-7F81AA4A14B3Q33911849-C63DA849-8EA0-406F-BEA5-86666A4E392DQ33912037-6069E60B-7C25-4768-8274-6F6210AB6652Q33962846-F2AA59CC-9F58-42F8-9F83-1743E0CE8BB9Q33966596-F5F97C66-B995-4A8C-98C7-08D5B8BB9AA8Q34058765-3DF27573-FE97-42CA-B222-F90587327F0FQ34389449-9819D95E-10A6-4E5F-BECF-FA1DBCFAC613Q35636029-C8F65042-BBFC-410F-A531-580ECCE36DB6Q35839778-A73E7AAF-B20F-4799-91E4-9CF25CDD07E3Q35857480-0D78F4C5-8BE4-4A7D-82E5-D758060BCD3AQ36086223-F681F328-6CFF-4AE6-8260-F44297961BEFQ36094944-706B94F8-7CC5-4F19-81C1-0FBE74C81F52Q36315149-C33E3AA5-D129-4FD9-9F39-D1BC5F84970AQ36371387-B57C98F2-89D6-43F9-B48E-51AF03E62474Q36403587-CC222484-594B-45F2-B032-37E7EF06F26AQ36629200-5B16F5DD-2F3F-423D-B5FC-F2F05EE0564AQ36637244-E6E718CF-9863-4720-847A-027543B036BBQ36648079-8713046E-651A-4C2E-A394-0EE1D4F3CF1AQ36797933-C3AA19DC-9288-4A39-964A-A8F2D9CB0697Q37072022-649A0DE1-472C-48D0-8127-6FFD0E3C8FADQ37209412-5D13DAB5-403B-49BA-B792-2281F276C37BQ37263490-AD9B187F-CEB6-4311-AD26-94C275FD12DAQ39551124-404F5FF8-E7B3-4CC1-ABCF-D00F9E9C3A15Q39578487-4FC57542-96E9-47AD-9636-F2263B1E0E8BQ39579642-5351BD80-D33B-40E8-8068-3008E690E44CQ39581028-89D3A3B8-1A57-4A99-902C-DFC60C6AEA4CQ39603745-7FFDC32B-98CC-4652-8B29-FE11B5DDD40CQ39872888-F41C6961-9A52-41BA-9DFE-69D42D289162Q39875204-E4F85803-8FFA-43D1-8453-CFC4CAD33753Q39878225-E15B2D49-0A30-477E-B565-9BBFA40E63B8Q40065815-BF67B3B1-E140-4D8F-B96F-2FE2D60C3163Q40334334-624B1157-B966-46E7-9441-67F2BA870B68Q40594947-7940FB5E-6429-4E81-A466-DBB8E8DE5DECQ58711298-ECEB7F0F-DB28-41F0-8015-1CDFAC802D2D
P2860
Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Biological and molecular varia ...... ype 2 isolates from The Gambia
@en
type
label
Biological and molecular varia ...... ype 2 isolates from The Gambia
@en
prefLabel
Biological and molecular varia ...... ype 2 isolates from The Gambia
@en
P2093
P2860
P1433
P1476
Biological and molecular varia ...... ype 2 isolates from The Gambia
@en
P2093
P2860
P304
P407
P577
1990-10-01T00:00:00Z